Friday, July 10, 2026

pharma · Primary Biliary Cholangitis · Pyoderma Gangrenosum

PHARMACEUTICAL ENTERPRISES

PHARMACEUTICAL ENTERPRISES clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Cape Town, GB HQ
1984 Founded
15 Employees
EMA registrant Type
Company details
Status
Public
HQ
Cape Town, GB
Founded
1984
Employees
15
Programs
3
Drugs
1
Patents
0
Intelligence · Clinical Programs

PHARMACEUTICAL ENTERPRISES projects

3 ClinicalTrials.gov programs sponsored by PHARMACEUTICAL ENTERPRISES.

PHARMACEUTICAL ENTERPRISES has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. APD334

    Arena Pharmaceutical Enterprises Limited

    Primary Biliary Cholangitis

    phase 2 small molecule terminated

    1 trial
  2. APD334

    Arena Pharmaceutical Enterprises Limited

    Pyoderma Gangrenosum

    phase 2 small molecule terminated

    1 trial
  3. Etrasimod

    Arena Pharmaceutical Enterprises Limited

    Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does PHARMACEUTICAL ENTERPRISES have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.